
Innovassynth (INOVSYNTH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
0
Gross Profit
0
Operating Income
-880.0K
Net Income
39.8M
Balance Sheet Metrics
Total Assets
486.0M
Total Liabilities
63.5M
Shareholders Equity
422.4M
Debt to Equity
0.15
Cash Flow Metrics
Revenue & Profitability Trend
Innovassynth Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 1.7M | 1.8M | 1.9M | 1.2M |
Other Operating Expenses | 3.1M | 884.0K | 1.1M | 656.0K | 1.9M |
Total Operating Expenses | 3.1M | 2.6M | 2.8M | 2.6M | 3.1M |
Operating Income | -4.2M | -3.5M | -3.7M | -3.7M | -2.8M |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 4.0M | 3.4M | 3.0M | 2.7M | 2.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -46.9M | -8.4M | -15.8M | 12.2M | -5.2M |
Income Tax | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -46.9M | -8.4M | -15.8M | 12.2M | -5.2M |
Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Key Metrics | |||||
EBITDA | -39.5M | -5.0M | -12.7M | 14.9M | -2.8M |
EPS (Basic) | - | ₹-0.35 | ₹-0.65 | ₹0.50 | ₹-0.21 |
EPS (Diluted) | - | ₹-0.35 | ₹-0.65 | ₹0.50 | ₹-0.21 |
Basic Shares Outstanding | - | 24278035 | 24278035 | 24278035 | 24828571 |
Diluted Shares Outstanding | - | 24278035 | 24278035 | 24278035 | 24828571 |
Income Statement Trend
Innovassynth Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 530.0K | 112.0K | 207.0K | 39.0K | 39.0K |
Short-term Investments | 25.0K | 5.0K | 5.0K | 5.0K | 5.0K |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | 132.0K | -22.0K | 27.0K | 12.0K | 35.0K |
Total Current Assets | 687.0K | 112.0K | 239.0K | 56.0K | 79.0K |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | 6.0K | 9.0K | 15.0K |
Total Non-Current Assets | 485.3M | 412.1M | 413.5M | 407.4M | 229.9M |
Total Assets | 486.0M | 412.2M | 413.8M | 407.5M | 230.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.4M | 1.4M | 1.2M | 1.2M | 577.0K |
Short-term Debt | 44.0M | 35.9M | 32.4M | 28.5M | 25.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 542.0K | 114.0K | 61.0K | 24.0K | -1.0K |
Total Current Liabilities | 63.5M | 51.5M | 44.6M | 37.9M | 31.5M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 0 | 0 | 2.0K | 0 | 1.0K |
Total Liabilities | 63.5M | 51.5M | 44.6M | 37.9M | 31.5M |
Equity | |||||
Common Stock | 279.8M | 242.8M | 242.8M | 242.8M | 242.8M |
Retained Earnings | - | -47.9M | -39.5M | -23.7M | -35.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 422.4M | 360.7M | 369.2M | 369.6M | 198.6M |
Key Metrics | |||||
Total Debt | 44.0M | 35.9M | 32.4M | 28.5M | 25.0M |
Working Capital | -62.9M | -51.3M | -44.4M | -37.8M | -31.4M |
Balance Sheet Composition
Innovassynth Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -46.9M | -8.4M | -15.8M | 12.2M | -5.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 188.0K | 37.0K | 56.0K | -41.0K | -16.0K |
Operating Cash Flow | -42.7M | -5.0M | -12.7M | 14.8M | -2.8M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 8.1M | 3.5M | 3.9M | 3.5M | 2.7M |
Free Cash Flow | -7.3M | -3.3M | -3.4M | -3.2M | -2.8M |
Net Change in Cash | -34.6M | -1.5M | -8.8M | 18.3M | -77.0K |
Cash Flow Trend
Innovassynth Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
140.85
Price to Book
7.04
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
-11.10%
Return on Assets
-9.65%
Financial Health
Current Ratio
0.01
Debt to Equity
10.41
Beta
0.06
Per Share Data
EPS (TTM)
₹-1.79
Book Value per Share
₹15.06
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
inovsynth | 3.0B | 140.85 | 7.04 | -11.10% | 0.00% | 10.41 |
Asian Paints | 2.5T | 68.41 | 12.69 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 72.37 | 16.14 | 20.85% | 16.16% | 4.56 |
Balaji Amines | 49.9B | 32.74 | 2.70 | 7.80% | 11.11% | 0.55 |
Tanfac Industries | 48.0B | 49.83 | 15.40 | 32.50% | 15.83% | 13.28 |
Grauer & Weil | 42.8B | 28.49 | 4.55 | 16.74% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.